Neonates, or newborns, are particularly vulnerable to infections due to their immature immune systems. Traditional antibiotic treatments can sometimes lead to adverse side effects and the development of antibiotic-resistant bacteria. Phage therapy offers a targeted approach, potentially reducing these risks.
